Venus Remedies Ltd
Venus Remedies | 526953
VENUSREM - Share Price Chart
Stock Performance
Ratios
About Company
- Incorporated in 1989 Venus Remedies Limited, formerly known as Venus Glucose Pvt Ltd, was converted into Public Limited Company in 1994 and then changed into Venus Remedies Limited
- The Company was promoted and managed by Chaudhary & Family
- The Company is one of the handful player in pharmaceutical sector to launch injectables globally
- It has manufacturing facilities in Panchkula and Baddi , and research and development centre under the name of Venus Medicine Research Centre (in India)
- At present, Venus focuses on specialized therapeutic areas including anti-infectives (antibiotics), oncology, neurology, pain management, and skin and wound care
- In priority, the Company was mainly engaged in I/V Fluids & Injectables, Ceftazidime, Amlodipine, Gliclazide, Lisinopril, etc
- The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana
- In 1994 it introduced Eye/Ear/Nose drops
- The company received the certificate as 'WHO-GMP' as specified by WHO,Geneva
- Venus Remedies set up a Cephalosporin project with an Australian collaboration with US-FDA standards at a cost of Rs
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Losers
Group Stocks
Frequently Asked Questions
What is Share Price of Venus Remedies Ltd?
The current share price of Venus Remedies Ltd (Venus Remedies) is ₹1681.00. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Venus Remedies Ltd?
The Price-to-Earnings (P/E) ratio of Venus Remedies Ltd is 19.34. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Venus Remedies Ltd?
Venus Remedies Ltd has a 52-week high of ₹2044.30 and a 52-week low of ₹432.10. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Venus Remedies Ltd?
Venus Remedies Ltd offers a dividend yield of 0.60%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Venus Remedies Ltd?
The Earnings Per Share (EPS) of Venus Remedies Ltd is ₹86.92. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Venus Remedies Ltd?
Venus Remedies Ltd has a Return on Equity (ROE) of 15.53%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
